BACKGROUND: High field magnetic resonance imaging (MRI) provides higher lesion load measurements in patients presenting with clinically isolated syndromes (CIS) suggestive of demyelination and has impact upon the classification of these syndromes and potentially, the diagnosis of multiple sclerosis (MS). PURPOSE: To investigate whether high field MRI can provide an earlier diagnosis of definite MS within the International Panel (IP) and Swanton criteria. METHODS: Forty patients presenting with CIS suggestive of MS were included. All patients received multi-sequence MRI at 1.5 Tesla (T) and 3T as well as a neurological assessment at baseline. Follow-up visits including MRI at both field strengths and neurological examinations were scheduled 3-4 and 6-7 months after the first clinical event. Based on MRI and clinical findings, fulfilled IP criteria as well as Swanton criteria were analysed. RESULTS: At baseline, the higher detection rate of inflammatory lesions using high field MRI leads to higher classifications according to the Swanton criteria in 15 % of the patients. One additional patient was diagnosed with dissemination in space according to Swanton and IP criteria. During follow-up, an earlier diagnosis of definite MS could not be accomplished, neither according to the IP nor to the Swanton criteria. CONCLUSION: Although high field MRI shows a higher detection rate of inflammatory brain lesion in CIS and MS patients with an influence according to MRI criteria, this influence does not lead to an earlier diagnosis of lesion dissemination in time and therefore definite MS.
BACKGROUND: High field magnetic resonance imaging (MRI) provides higher lesion load measurements in patients presenting with clinically isolated syndromes (CIS) suggestive of demyelination and has impact upon the classification of these syndromes and potentially, the diagnosis of multiple sclerosis (MS). PURPOSE: To investigate whether high field MRI can provide an earlier diagnosis of definite MS within the International Panel (IP) and Swanton criteria. METHODS: Forty patients presenting with CIS suggestive of MS were included. All patients received multi-sequence MRI at 1.5 Tesla (T) and 3T as well as a neurological assessment at baseline. Follow-up visits including MRI at both field strengths and neurological examinations were scheduled 3-4 and 6-7 months after the first clinical event. Based on MRI and clinical findings, fulfilled IP criteria as well as Swanton criteria were analysed. RESULTS: At baseline, the higher detection rate of inflammatory lesions using high field MRI leads to higher classifications according to the Swanton criteria in 15 % of the patients. One additional patient was diagnosed with dissemination in space according to Swanton and IP criteria. During follow-up, an earlier diagnosis of definite MS could not be accomplished, neither according to the IP nor to the Swanton criteria. CONCLUSION: Although high field MRI shows a higher detection rate of inflammatory brain lesion in CIS and MS patients with an influence according to MRI criteria, this influence does not lead to an earlier diagnosis of lesion dissemination in time and therefore definite MS.
Authors: M Tintoré; A Rovira; M J Martínez; J Rio; P Díaz-Villoslada; L Brieva; C Borrás; E Grivé; J Capellades; X Montalban Journal: AJNR Am J Neuroradiol Date: 2000-04 Impact factor: 3.825
Authors: M P Wattjes; M Harzheim; C K Kuhl; J Gieseke; S Schmidt; L Klotz; T Klockgether; H H Schild; G G Lutterbey Journal: AJNR Am J Neuroradiol Date: 2006-09 Impact factor: 3.825
Authors: J H Simon; D Li; A Traboulsee; P K Coyle; D L Arnold; F Barkhof; J A Frank; R Grossman; D W Paty; E W Radue; J S Wolinsky Journal: AJNR Am J Neuroradiol Date: 2006-02 Impact factor: 3.825
Authors: Kirsten Nielsen; Egill Rostrup; Jette L Frederiksen; Stine Knudsen; Henrik K Mathiesen; Lars G Hanson; Olaf B Paulson Journal: Invest Radiol Date: 2006-02 Impact factor: 6.016
Authors: J C J Bot; F Barkhof; C H Polman; G J Lycklama à Nijeholt; V de Groot; E Bergers; H J Ader; J A Castelijns Journal: Neurology Date: 2004-01-27 Impact factor: 9.910
Authors: J K Swanton; K Fernando; C M Dalton; K A Miszkiel; A J Thompson; G T Plant; D H Miller Journal: J Neurol Neurosurg Psychiatry Date: 2005-07-25 Impact factor: 10.154
Authors: Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky Journal: Ann Neurol Date: 2005-12 Impact factor: 10.422
Authors: C M Dalton; P A Brex; K A Miszkiel; K Fernando; D G MacManus; G T Plant; A J Thompson; D H Miller Journal: J Neurol Neurosurg Psychiatry Date: 2003-11 Impact factor: 10.154
Authors: D H Miller; M Filippi; F Fazekas; J L Frederiksen; P M Matthews; X Montalban; C H Polman Journal: Ann Neurol Date: 2004-08 Impact factor: 10.422
Authors: W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky Journal: Ann Neurol Date: 2001-07 Impact factor: 10.422
Authors: Joanna M Wardlaw; Will Brindle; Ana M Casado; Kirsten Shuler; Moira Henderson; Brenda Thomas; Jennifer Macfarlane; Susana Muñoz Maniega; Katherine Lymer; Zoe Morris; Cyril Pernet; William Nailon; Trevor Ahearn; Abdul Nashirudeen Mumuni; Carlos Mugruza; John McLean; Goultchira Chakirova; Yuehui Terry Tao; Johanna Simpson; Andrew C Stanfield; Harriet Johnston; Jehill Parikh; Natalie A Royle; Janet De Wilde; Mark E Bastin; Nick Weir; Andrew Farrall; Maria C Valdes Hernandez Journal: Eur Radiol Date: 2012-06-09 Impact factor: 5.315
Authors: Wolter L de Graaf; Iris D Kilsdonk; Alexandra Lopez-Soriano; Jaco J M Zwanenburg; Fredy Visser; Chris H Polman; Jonas A Castelijns; Jeroen J G Geurts; Petra J W Pouwels; Peter R Luijten; Frederik Barkhof; Mike P Wattjes Journal: Eur Radiol Date: 2012-08-17 Impact factor: 5.315